Sagent Pharmaceuticals, Inc.(NASDAQ : SGNT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.04%||172.25||0.7%||$1088.53m|
|MRK||Merck & Co., Inc.||-0.13%||76.83||0.7%||$651.89m|
|BMY||Bristol-Myers Squibb Co.||-0.34%||67.92||1.0%||$580.36m|
|LLY||Eli Lilly & Co.||-0.80%||243.36||1.1%||$577.91m|
|NRXP||NRX Pharmaceuticals, Inc.||0.20%||15.18||0.0%||$167.78m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-0.06%||126.06||0.0%||$85.37m|
|NVO||Novo Nordisk A/S||1.32%||92.58||0.1%||$81.36m|
|RPRX||Royalty Pharma Plc||-0.13%||38.20||0.2%||$73.90m|
Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.